Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis a virus antigen, quantity: 720 elisa unit - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; aluminium; polysorbate 20; dibasic sodium phosphate heptahydrate; monobasic potassium phosphate; sodium chloride; potassium chloride; water for injections; acetic acid; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate; glycine - havrix is indicated for active immunisation against hepatitis a virus (hav) infection in susceptible subjects at risk of exposure to hav. havrix junior is indicated in subjects aged 2 to 15 years and havrix 1440 is indicated in subjects aged 16 years and older. in areas of low prevalence of hepatitis a, immunisation with havrix is particularly recommended in the following subjects: travellers : persons travelling to areas of intermediate or high endemicity for hepatitis a. these areas include africa, asia, india, the pacific islands, the mediterranean basin, the middle east, central and south america. armed forces : armed forces personnel who travel to higher endemicity areas or to areas where hygiene is poor, have an increased risk of hav infection. persons for whom hepatitis a is an occupational hazard or for whom there is an increased risk of transmission. these include: employees in day-care centres particularly in situations where children have not been toilet trained; teachers and other close contacts o

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis a virus antigen, quantity: 720 elisa unit - injection, suspension - excipient ingredients: aluminium hydroxide hydrate; aluminium; polysorbate 20; dibasic sodium phosphate heptahydrate; monobasic potassium phosphate; sodium chloride; potassium chloride; water for injections; acetic acid; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate; glycine - havrix is indicated for active immunisation against hepatitis a virus (hav) infection in susceptible subjects at risk of exposure to hav. havrix junior is indicated in subjects aged 2 to 15 years and havrix 1440 is indicated in subjects aged 16 years and older. in areas of low prevalence of hepatitis a, immunisation with havrix is particularly recommended in the following subjects: travellers : persons travelling to areas of intermediate or high endemicity for hepatitis a. these areas include africa, asia, india, the pacific islands, the mediterranean basin, the middle east, central and south america. armed forces : armed forces personnel who travel to higher endemicity areas or to areas where hygiene is poor, have an increased risk of hav infection. persons for whom hepatitis a is an occupational hazard or for whom there is an increased risk of transmission. these include: employees in day-care centres particularly in situations where children have not been toilet trained; teachers and other close contacts of the intellectually disabled; staff and residents of residential facilities for the intellectually disabled; health workers and teachers in remote aboriginal and torres strait islander communities; nursing staff and other healthcare workers in contact with patients in paediatric wards, infectious diseases wards, emergency rooms and intensive care units sewerage workers ; food handlers, since food hygiene procedures and food processing methods are not always adequate to protect from contamination from food handlers. homosexual men : increased incidence of hepatitis a infection among homosexual males suggests that the disease may be sexually transmitted in this group. contacts of infected persons : since virus shedding from infected persons may occur for a prolonged period, active immunisation of close contacts is recommended. the use of vaccine in outbreak control has been shown to be more effective than the use of immunoglobulin. specific population groups known to have a higher incidence of hepatitis a: eg. australian aboriginals, recognised community-wide hav epidemics. individuals with chronic liver disease and recipients of liver transplants, as hepatitis a infections is likely to be more severe in these groups. many injecting drug users will have pre-existing liver disease from hepatitis b or hepatitis c infection. recipients of blood products, such as factor viii eg. haemophiliacs. havrix will not prevent hepatitis infection caused by other agents such as hepatitis b virus, hepatitis c virus, hepatitis d virus, hepatitis e or other pathogens known to infect the liver.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis a virus antigen, quantity: 1440 elisa unit - injection, suspension - excipient ingredients: polysorbate 20; dibasic sodium phosphate heptahydrate; monobasic potassium phosphate; sodium chloride; potassium chloride; water for injections; aluminium hydroxide hydrate; acetic acid; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate; glycine - havrix is indicated for active immunisation against hepatitis a virus (hav) infection in susceptible subjects at risk of exposure to hav. havrix junior is indicated in subjects aged 2 to 15 years and havrix 1440 is indicated in subjects aged 16 years and older. in areas of low prevalence of hepatitis a, immunisation with havrix is particularly recommended in the following subjects: travellers : persons travelling to areas of intermediate or high endemicity for hepatitis a. these areas include africa, asia, india, the pacific islands, the mediterranean basin, the middle east, central and south america. armed forces : armed forces personnel who travel to higher endemicity areas or to areas where hygiene is poor, have an increased risk of hav infection. persons for whom hepatitis a is an occupational hazard or for whom there is an increased risk of transmission. these include: employees in day-care centres particularly in situations where children have not been toilet trained; teachers and other close contacts o

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis a virus antigen, quantity: 1440 elisa unit - injection, suspension - excipient ingredients: polysorbate 20; dibasic sodium phosphate heptahydrate; monobasic potassium phosphate; sodium chloride; potassium chloride; water for injections; aluminium hydroxide hydrate; acetic acid; leucine; phenylalanine; methionine; lysine hydrochloride; isoleucine; valine; histidine; threonine; tryptophan; alanine; arginine; proline; tyrosine; serine; sodium acetate; dibasic potassium phosphate; magnesium chloride hexahydrate; glycine - havrix is indicated for active immunisation against hepatitis a virus (hav) infection in susceptible subjects at risk of exposure to hav. havrix junior is indicated in subjects aged 2 to 15 years and havrix 1440 is indicated in subjects aged 16 years and older. in areas of low prevalence of hepatitis a, immunisation with havrix is particularly recommended in the following subjects: travellers : persons travelling to areas of intermediate or high endemicity for hepatitis a. these areas include africa, asia, india, the pacific islands, the mediterranean basin, the middle east, central and south america. armed forces : armed forces personnel who travel to higher endemicity areas or to areas where hygiene is poor, have an increased risk of hav infection. persons for whom hepatitis a is an occupational hazard or for whom there is an increased risk of transmission. these include: employees in day-care centres particularly in situations where children have not been toilet trained; teachers and other close contacts of the intellectually disabled; staff and residents of residential facilities for the intellectually disabled; health workers and teachers in remote aboriginal and torres strait islander communities; nursing staff and other healthcare workers in contact with patients in paediatric wards, infectious diseases wards, emergency rooms and intensive care units sewerage workers ; food handlers, since food hygiene procedures and food processing methods are not always adequate to protect from contamination from food handlers. homosexual men : increased incidence of hepatitis a infection among homosexual males suggests that the disease may be sexually transmitted in this group. contacts of infected persons : since virus shedding from infected persons may occur for a prolonged period, active immunisation of close contacts is recommended. the use of vaccine in outbreak control has been shown to be more effective than the use of immunoglobulin. specific population groups known to have a higher incidence of hepatitis a: eg. australian aboriginals, recognised community-wide hav epidemics. individuals with chronic liver disease and recipients of liver transplants, as hepatitis a infections is likely to be more severe in these groups. many injecting drug users will have pre-existing liver disease from hepatitis b or hepatitis c infection. recipients of blood products, such as factor viii eg. haemophiliacs. havrix will not prevent hepatitis infection caused by other agents such as hepatitis b virus, hepatitis c virus, hepatitis d virus, hepatitis e or other pathogens known to infect the liver.

USA - engelsk - NLM (National Library of Medicine)

forces of nature - urtica dioica whole (unii: 710flw4u46) (urtica dioica whole - unii:710flw4u46), althaea officinalis root (unii: trw2fuf47h) (althaea officinalis root - unii:trw2fuf47h), inula helenium root (unii: e55smd6da8) (inula helenium root - unii:e55smd6da8), angelica archangelica root (unii: dtn01m69sn) (angelica archangelica root - unii:dtn01m69sn), pine needle oil (pinus sylvestris) (unii: 5exl5h740y) (pine needle oil (pinus sylvestris) - unii:5exl5h740y), sodium chloride (unii: 451w47iq8x) (chloride ion - u - for the relief of allergy related ailments. symptoms include: - hay fever - hives/rashes - itchy eyes - sinus congestion - respiratory issues - inflammation

USA - engelsk - NLM (National Library of Medicine)

forces of nature - holy basil leaf (unii: scj765569p) (holy basil leaf - unii:scj765569p), berberis vulgaris root (unii: itj40jx79u) (berberis vulgaris root - unii:itj40jx79u), garlic (unii: v1v998dc17) (garlic - unii:v1v998dc17), thuja occidentalis leaf (unii: 0t0dqn8786) (thuja occidentalis leaf - unii:0t0dqn8786), echinacea angustifolia root (unii: d982v7vt3p) (echinacea angustifolia root - unii:d982v7vt3p), silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4) - for the relief of sinus related ailments. symptoms include: - nasal congestion - sinus pressure - itchy/runny nose

USA - engelsk - NLM (National Library of Medicine)

forces of nature - european elderberry (unii: bqy1ubx046) (european elderberry - unii:bqy1ubx046), berberis vulgaris root (unii: itj40jx79u) (berberis vulgaris root - unii:itj40jx79u), solidago canadensis flowering top (unii: zhl562l3pr) (solidago canadensis flowering top - unii:zhl562l3pr), achillea millefolium flowering top (unii: 55862q3xeu) (achillea millefolium flowering top - unii:55862q3xeu), holy basil leaf (unii: scj765569p) (holy basil leaf - unii:scj765569p), garlic (unii: v1v998dc17) (garlic - unii:v1v998dc1 - for the relief of respiratory ailments (cold & flu). symptoms include: - cough - body aches - fever - nasal congestion - respiratory issues - sinus pressure

USA - engelsk - NLM (National Library of Medicine)

forces of nature - arnica montana whole (unii: o80ty208zw) (arnica montana whole - unii:o80ty208zw), horse chestnut (unii: 3c18l6rjaz) (horse chestnut - unii:3c18l6rjaz), hypericum perforatum whole (unii: xk4iux8mnb) (hypericum perforatum whole - unii:xk4iux8mnb), ruta graveolens whole (unii: 181ji0338p) (ruta graveolens whole - unii:181ji0338p), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37) - relieves back pain and soreness due to overuse, strain, spasm, or trauma.

USA - engelsk - NLM (National Library of Medicine)

forces of nature - taraxacum officinale root (unii: 9de5yco0ru) (taraxacum officinale root - unii:9de5yco0ru), verbena hastata top (unii: cmj753697i) (verbena hastata top - unii:cmj753697i), lactuca virosa leaf (unii: h3r170z9h8) (lactuca virosa leaf - unii:h3r170z9h8), chamomile flower oil (unii: 60f80z61a9) (chamomile flower oil - unii:60f80z61a9), arabica coffee bean (unii: 3sw678mx72) (arabica coffee bean - unii:3sw678mx72), scutellaria lateriflora whole (unii: 7bp4dh5pdc) (scutellaria lateriflora whole - unii:7bp4 - to help focus mental abilities and restore calm thinking.

USA - engelsk - NLM (National Library of Medicine)

forces of nature - garlic (unii: v1v998dc17) (garlic - unii:v1v998dc17), avena sativa top (unii: 1zx4oxu3n6) (avena sativa top - unii:1zx4oxu3n6), angelica archangelica root (unii: dtn01m69sn) (angelica archangelica root - unii:dtn01m69sn), arabica coffee bean (unii: 3sw678mx72) (arabica coffee bean - unii:3sw678mx72), holy basil leaf (unii: scj765569p) (holy basil leaf - unii:scj765569p), passiflora edulis flower (unii: sy49th8vua) (passiflora edulis flower - unii:sy49th8vua), scutellaria lateriflora (unii: 7bp4dh5pdc) - for the relief of nervousness and tension often associated with stress/anxiety.